Cargando…
Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?
Tumors engineered to express the costimulatory molecule B7-1 can elicit CD8+ cytotoxic T lymphocyte (CTL)-dependent antitumor responses in immunocompetent mice. It has been postulated that this result reflects direct priming of CTL by the modified tumor in vivo. Previous studies of the immune respon...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192347/ https://www.ncbi.nlm.nih.gov/pubmed/8642281 |
Ejemplares similares
-
Capacities of Migrating CD1b(+) Lymph Dendritic Cells to Present Salmonella Antigens to Naive T Cells
por: Olivier, Michel, et al.
Publicado: (2012) -
In Vivo
MRI Tracking of Tumor Vaccination and Antigen Presentation by Dendritic Cells
por: Bulte, Jeff W. M., et al.
Publicado: (2021) -
Antigen presenting capacity of murine splenic myeloid cells
por: Hey, Ying-Ying, et al.
Publicado: (2017) -
Antigen Presentation by Dendritic Cells In Vivo
por: Mougneau, Evelyne, et al.
Publicado: (2002) -
Endothelial cells present antigens in vivo
por: Rothermel, Annette L, et al.
Publicado: (2004)